Skip to content

Drug interactions

Crizotinib + Vinblastine

Severity: Major

Crizotinib and Vinblastine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Crizotinib inhibits CYP3A4 and P-glycoprotein, both of which clear vinblastine. Higher vinblastine levels may increase myelosuppression, neurotoxicity and constipation.

What this interaction means in plain words

Crizotinib and Vinblastine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Crizotinib belongs to Oncology; Vinblastine belongs to Oncology.

Evidence level: Low

Why it happens

Crizotinib inhibits CYP3A4 metabolism and P-glycoprotein efflux of vinblastine.

What to do

Monitor blood counts and for neurotoxicity and ileus, and reduce the vinblastine dose if toxicity develops. Consider alternatives to crizotinib where feasible.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Vinblastine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Crizotinib with Vinblastine?

MediHelp rates the interaction as major. Crizotinib and Vinblastine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Crizotinib inhibits CYP3A4 and P-glycoprotein, both of which clear vinblastine. Higher vinblastine levels may increase myelosuppression, neurotoxicity and constipation.

How serious is the interaction between Crizotinib and Vinblastine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and for neurotoxicity and ileus, and reduce the vinblastine dose if toxicity develops. Consider alternatives to crizotinib where feasible.

What other medicines interact with Vinblastine?

MediHelp also lists interactions of Vinblastine with, for example, Adenovirus types 4 and 7 live, Apalutamide, Atazanavir. The full list is on the Vinblastine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in